34 results on '"Pavlova, Sarka"'
Search Results
2. Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits
3. Mobile retroelements induced by hypomethylating agents are restricted to transpose in myeloid malignancies
4. Supplementary Table 1 from Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia
5. Supplementary Table 1 from Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia
6. Detection and Functional Analysis of TP53 Mutations in CLL
7. Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage
8. Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene
9. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
10. The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia
11. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
12. Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene
13. PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells
14. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience
15. ToTem: a tool for variant calling pipeline optimization
16. Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia
17. Low-Burden TP53 Mutations Occur in Chronic Phase of Myeloproliferative Neoplasms Regardless of Hydroxyurea Administration, Disease Type, and JAK2 Status
18. DecreasedWNT3expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutatedIGHV
19. Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia
20. TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods
21. Prognostic Impact of NOTCH1 Hotspot Mutation in TP53-Mutated Patients with Chronic Lymphocytic Leukemia
22. TP53 Mutation Analysis in Clinical Practice: Lessons From Chronic Lymphocytic Leukemia
23. Clonal Evolution and Therapy Related Selection Of TP53 Mutations In Chronic Lymphocytic Leukemia Patients
24. Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 Mutations to Chemotherapy.
25. Microrna-34a As a Marker for Fludarabine Resistance and Impairment of p53-Pathway in Chronic Lymphocytic Leukemia
26. Gene expression profiling of acute graft-vs-host disease after hematopoietic stem cell transplantation
27. MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia
28. The Regulation, Targets and Clinical Relevance of Microrna Mir-650 in Chronic Lymphocytic Leukemia (CLL),
29. Mutational Analysis of Mir-29 Family Members in Chronic Lymphocytic Leukemia
30. 4.23 MDM2 Promotor Polymorphism and Disease Characteristics in CLL: Individual Patient Data Meta-Analysis of 2598 CLL Patients
31. Clonal Evolution of Malignant Populations In Potentially Biclonal Chronic Lymphocytic Leukemia Patients
32. Detail Characterization of 22q11 Deletion and Mir-650 Role in CLL Patients.
33. Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma
34. High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.